Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.33M Sell
15,908
-736
-4% -$133K 0.07% 231
2026
Q1
$2.45M Buy
16,644
+931
+6% +$151K 0.07% 232
2025
Q4
$3.06M Sell
15,713
-351
-2% -$83.6K 0.09% 170
2025
Q3
$4.52M Sell
16,064
-798
-5% -$203K 0.14% 151
2025
Q2
$3.69M Buy
16,862
+748
+5% +$121K 0.13% 155
2025
Q1
$2.25M Buy
16,114
+737
+5% +$120K 0.09% 188
2024
Q4
$2.56M Buy
15,377
+547
+4% +$97.2K 0.1% 161
2024
Q3
$2.53M Sell
14,830
-22,722
-61% -$3.29M 0.11% 181
2024
Q2
$5.3M Sell
37,552
-1,240
-3% -$154K 0.25% 102
2024
Q1
$4.87M Buy
38,792
+24,737
+176% +$2.83M 0.23% 102
2023
Q4
$1.48M Sell
14,055
-73
-0.5% -$7.97K 0.08% 209
2023
Q3
$1.5M Sell
14,128
-37
-0.3% -$4.28K 0.08% 210
2023
Q2
$1.69M Sell
14,165
-79
-0.6% -$8.17K 0.09% 227
2023
Q1
$1.33M Sell
14,244
-36,938
-72% -$3.24M 0.07% 257
2022
Q4
$4.18M Buy
51,182
+13,544
+36% +$1.03M 0.25% 103
2022
Q3
$2.3M Buy
37,638
+30,131
+401% +$2.21M 0.16% 158
2022
Q2
$524K Sell
7,507
-761
-9% -$55.7K 0.04% 329
2022
Q1
$684K Buy
8,268
+630
+8% +$51K 0.05% 250
2021
Q4
$666K Sell
7,638
-24,664
-76% -$2.32M 0.05% 227
2021
Q3
$2.81M Sell
32,302
-1,042
-3% -$92K 0.23% 113
2021
Q2
$2.6M Sell
33,344
-4,708
-12% -$369K 0.21% 113
2021
Q1
$2.67M Sell
38,052
-48,327
-56% -$3.13M 0.24% 104
2020
Q4
$5.59M Sell
86,379
-19,818
-19% -$1.18M 0.54% 46
2020
Q3
$6.34M Buy
106,197
+13,746
+15% +$781K 0.68% 42
2020
Q2
$5.11M Buy
92,451
+12,898
+16% +$683K 0.67% 34
2020
Q1
$3.85M Buy
79,553
+53,659
+207% +$2.77M 0.63% 36
2019
Q4
$1.37M Buy
25,894
+21,164
+447% +$1.17M 0.24% 87
2019
Q3
$260K Buy
4,730
+31
+0.7% +$1.71K 0.04% 201
2019
Q2
$268K Buy
4,699
+1,080
+30% +$58.4K 0.04% 201
2019
Q1
$194K Buy
3,619
+1,945
+116% +$99.1K 0.03% 216
2018
Q4
$76K Buy
1,674
+1,551
+1,261% +$74.3K 0.02% 224
2018
Q3
$6K Hold
123
﹤0.01% 287
2018
Q2
$5K Buy
+123
New +$5.67K ﹤0.01% 268

Other funds holding ORCL

CX Institutional's ORCL Position: Q2 2026 in Review

CX Institutional reduced its Oracle (ORCL) stake by 4.4% in Q2 2026, selling an estimated $133K and leaving 15,908 shares worth $2.33M. The position accounts for 0.07% of the portfolio, ranked #231.

CX Institutional first reported a position in ORCL in Q2 2018 and has held it in 33 quarters since. The position peaked at $6.34M in Q3 2020. 821 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • CX Institutional held 15,908 shares of Oracle worth $2.33M as of Q2 2026.
  • CX Institutional sold 736 Oracle shares in Q2 2026, an estimated $133K.
  • Oracle made up 0.07% of CX Institutional's portfolio in Q2 2026, its #231 holding.
  • CX Institutional first reported a position in Oracle in Q2 2018 and has held it in 33 quarters since.
  • CX Institutional's Oracle position peaked at $6.34M in Q3 2020.
  • 821 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.